Corporate News

Warrant Expiry and Block Admission Cancellation

10 November 2023

Cambridge Nutritional Sciences plc (AIM: CNSL), the specialist medical diagnostics company focused on promoting a personalised and functional approach to health and nutrition, announces that all warrants issued alongside its capital raise announced 6 May 2022 have now expired ("Warrants").

Further to the above the Company has made application to AIM to cancel the Company's Block Admission, which was originally established to facilitate the issuance of ordinary shares following receipt of any exercise of the Warrants (the "Cancellation"). The Cancellation will become effective Monday 13 November, as such no further interim returns will be published in relation to the Company's Block Admission. The Balance of ordinary shares under the Block Admission not issued/allotted at the time of Cancellation is 90,000,000.

 

Contacts: 

 

Cambridge Nutritional Sciences plc

  www.cnsplc.com

Jag Grewal, Chief Executive Officer 

via Walbrook PR



Cavendish Capital Markets Limited  

Tel: 020 7220 0500

Geoff Nash / Edward Whiley / George Dollemore (Corporate Finance)


Nigel Birks / Harriet Ward (ECM)




Walbrook PR Limited

Tel: 020 7933 8780 or [email protected]

Paul McManus / Charlotte Edgar

Mob: 07980 541 893 / 07884 664 686

Sam Allen

Mob: 07502 558 258

 

About Cambridge Nutritional Sciences plc

Cambridge Nutritional Sciences plc (AIM: CNSL) is a specialist medical diagnostics company focused on industry-leading Health and Nutrition products.

Sign up for Investor Alerts